Aspireo Receives Positive Opinion from EMA for Orphan Disease Designation for Somatoprim

News   Nov 26, 2012

 
Aspireo Receives Positive Opinion from EMA for Orphan Disease Designation for Somatoprim
 
 
 

RELATED ARTICLES

Key Psychiatric Drug Target Comes Into Focus

News

Researchers have determined the crystal structure of a specific dopamine receptor called D4 at an incredibly high resolution which is a major step towards designing improved psychiatric drugs with fewer side effects.

READ MORE

Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV Drug

News

Supplies of a promising drug for cancer, HIV and possibly other diseases is dwindling, and scientists have struggled to extract more from the marine creatures who produce it. Now, chemists have a synthetic solution.

READ MORE

Arsenic Trioxide Could Extend Lives of Patients with Aggressive Brain Cancer

News

Arsenic trioxide could be a powerful therapy that could extend the lives of certain glioblastoma patients by as much as three to four times the median expectation.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE